BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32822758)

  • 1. Urokinase receptor deficiency results in EGFR-mediated failure to transmit signals for cell survival and neurite formation in mouse neuroblastoma cells.
    Rysenkova KD; Klimovich PS; Shmakova AA; Karagyaur MN; Ivanova KA; Aleksandrushkina NA; Tkachuk VA; Rubina KA; Semina EV
    Cell Signal; 2020 Nov; 75():109741. PubMed ID: 32822758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
    Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
    Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
    Semina EV; Rubina KA; Shmakova AA; Rysenkova KD; Klimovich PS; Aleksanrushkina NA; Sysoeva VY; Karagyaur MN; Tkachuk VA
    J Cell Physiol; 2020 Sep; 235(9):6268-6286. PubMed ID: 31990070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
    Guerrero J; Santibañez JF; González A; Martínez J
    Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.
    Jo M; Thomas KS; O'Donnell DM; Gonias SL
    J Biol Chem; 2003 Jan; 278(3):1642-6. PubMed ID: 12426305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
    J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis.
    LaRusch GA; Mahdi F; Shariat-Madar Z; Adams G; Sitrin RG; Zhang WM; McCrae KR; Schmaier AH
    Blood; 2010 Jun; 115(24):5111-20. PubMed ID: 20228268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
    Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E
    Lian S; Xia Y; Ung TT; Khoi PN; Yoon HJ; Lee SG; Kim KK; Jung YD
    Mol Carcinog; 2017 Feb; 56(2):664-680. PubMed ID: 27377703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.
    Duru EA; Fu Y; Davies MG
    J Surg Res; 2014 Dec; 192(2):254-62. PubMed ID: 25082749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
    Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
    Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
    Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.
    Jo M; Takimoto S; Montel V; Gonias SL
    Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
    Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
    Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.